BLM seeks comments on American Prairie Reserve bison proposal
Daily Montanan Staff
View Comments
LEWISTOWN The Bureau of Land Management invites the public to comment on its draft environmental assessment and finding of no significant impact, often called a “FONSI” for a bison grazing proposal on BLM-administered lands located in Phillips County, Montana.
On Sept. 24, 2019, the American Prairie Reserve submitted a proposal (an update to their earlier proposal submitted on Nov. 20, 2017) to modify certain terms and conditions of seven BLM-administered grazing permits held by the APR. American Prairie Reserve’s original proposal, sought permit changes for 18 BLM grazing allotments located in four counties. BLM conducted public scoping April 9 through June 11, 2018, including public meetings held in those four counties. The BLM received 2,497 submissions which were reviewed and considered in determining the final set of issues to be included in the NEPA analysis.
BLM seeks public comments on draft EA, FONSI for updated bison grazing proposal
blm.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from blm.gov Daily Mail and Mail on Sunday newspapers.
Former TOR MD pays over $300,000 to settle US SEC bribery case
graphic.com.gh - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from graphic.com.gh Daily Mail and Mail on Sunday newspapers.
AI reveals current drugs that may help combat Alzheimer’s
New treatments for Alzheimer’s disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options. Now a team at Harvard-affiliated Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) has developed an artificial intelligence-based method to screen currently available medications as possible treatments for Alzheimer’s disease. The method could represent a rapid and inexpensive way to repurpose existing therapies into new treatments for this progressive, debilitating neurodegenerative condition. Importantly, it could also help reveal new, unexplored targets for therapy by pointing to mechanisms of drug action.